ASP Isotopes Inc. (NASDAQ:ASPI – Get Free Report) CEO Paul Mann sold 83,759 shares of the firm’s stock in a transaction that occurred on Friday, September 4th. The shares were sold at an average price of $4.10, for a total value of $343,411.90. Following the completion of the transaction, the chief executive officer directly owned 9,328,570 shares of the company’s stock, valued at $38,247,137. The trade was a 0.89% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Paul Elliot Mann also recently made the following trade(s):
- On Wednesday, September 2nd, Paul Mann sold 83,758 shares of ASP Isotopes stock. The stock was sold at an average price of $3.91, for a total value of $327,493.78.
ASP Isotopes Price Performance
ASPI traded up $0.30 during trading on Friday, reaching $4.20. 3,831,544 shares of the stock were exchanged, compared to its average volume of 2,936,087. The company has a debt-to-equity ratio of 0.76, a current ratio of 3.87 and a quick ratio of 3.85. The company has a market capitalization of $643.90 million, a price-to-earnings ratio of -3.18 and a beta of 3.59. ASP Isotopes Inc. has a 1 year low of $3.51 and a 1 year high of $14.49. The business’s 50 day moving average price is $4.37 and its two-hundred day moving average price is $5.20.
Institutional Trading of ASP Isotopes
Large investors have recently made changes to their positions in the stock. State of Wyoming acquired a new position in shares of ASP Isotopes during the 1st quarter valued at $29,000. Quantbot Technologies LP purchased a new position in ASP Isotopes in the third quarter valued at about $34,000. BNP Paribas Financial Markets raised its position in ASP Isotopes by 84.9% in the second quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company’s stock valued at $41,000 after purchasing an additional 2,548 shares during the period. Stephens Inc. AR acquired a new position in shares of ASP Isotopes during the first quarter worth about $44,000. Finally, Broadhurst Jeffrey B acquired a new position in shares of ASP Isotopes during the first quarter worth about $44,000. Institutional investors and hedge funds own 16.80% of the company’s stock.
Analyst Upgrades and Downgrades
Several equities analysts have weighed in on ASPI shares. Weiss Ratings restated a “sell (d-)” rating on shares of ASP Isotopes in a report on Wednesday, June 24th. Wall Street Zen raised shares of ASP Isotopes from a “strong sell” rating to a “sell” rating in a report on Saturday, August 22nd. Two research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat, ASP Isotopes has an average rating of “Hold” and an average price target of $13.00.
Read Our Latest Analysis on ASPI
About ASP Isotopes
ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.
Featured Stories
- Five stocks we like better than ASP Isotopes
- Revolution Medicines Got Its Breakthrough—What Moves It Next?
- Retail Earnings Just Exposed a Bigger Divide in the U.S. Consumer Economy
- FB Financial’s Southern Expansion and Buybacks Drive Analyst Optimism
- AST SpaceMobile Stock Soared 12%—This Was the Catalyst
Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.
